Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1992 1
1993 3
1994 1
1995 1
1997 1
1998 3
1999 2
2001 3
2003 2
2004 3
2005 2
2006 6
2007 3
2008 5
2009 5
2010 9
2011 10
2012 9
2013 5
2014 9
2015 7
2016 4
2017 14
2018 6
2019 5
2020 7
2021 7
2022 3
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Allele-specific copy number analysis of tumors.
Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN. Van Loo P, et al. Among authors: naume b. Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5. doi: 10.1073/pnas.1009843107. Epub 2010 Sep 13. Proc Natl Acad Sci U S A. 2010. PMID: 20837533 Free PMC article.
Late effects after breast cancer treatment.
Vandraas KF, Smedsland S, Engan HK, Kiserud C, Naume B, Brekke M, Reinertsen KV. Vandraas KF, et al. Among authors: naume b. Tidsskr Nor Laegeforen. 2023 Jul 14;143(11). doi: 10.4045/tidsskr.23.0017. Print 2023 Aug 15. Tidsskr Nor Laegeforen. 2023. PMID: 37589367 Free article. Review. English, Norwegian.
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial.
Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA. Røssevold AH, et al. Among authors: naume b. Nat Med. 2022 Dec;28(12):2573-2583. doi: 10.1038/s41591-022-02126-1. Epub 2022 Dec 8. Nat Med. 2022. PMID: 36482103 Free PMC article. Clinical Trial.
Bone marrow NG2+/Nestin+ mesenchymal stem cells drive DTC dormancy via TGFβ2.
Nobre AR, Risson E, Singh DK, Di Martino JS, Cheung JF, Wang J, Johnson J, Russnes HG, Bravo-Cordero JJ, Birbrair A, Naume B, Azhar M, Frenette PS, Aguirre-Ghiso JA. Nobre AR, et al. Among authors: naume b. Nat Cancer. 2021 Mar;2(3):327-339. doi: 10.1038/s43018-021-00179-8. Epub 2021 Mar 11. Nat Cancer. 2021. PMID: 34993493 Free PMC article.
Circulating and disseminated tumor cells.
Braun S, Naume B. Braun S, et al. Among authors: naume b. J Clin Oncol. 2005 Mar 10;23(8):1623-6. doi: 10.1200/JCO.2005.10.073. J Clin Oncol. 2005. PMID: 15755968 Review. No abstract available.
Minimal residual disease in breast cancer.
Kvalheim G, Naume B, Nesland JM. Kvalheim G, et al. Among authors: naume b. Cancer Metastasis Rev. 1999;18(1):101-8. doi: 10.1023/a:1006216504892. Cancer Metastasis Rev. 1999. PMID: 10505549 Review.
Breast cancer quantitative proteome and proteogenomic landscape.
Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF, Schlichting E, Naume B; Consortia Oslo Breast Cancer Research Consortium (OSBREAC); Luders T, Borgen E, Kristensen VN, Russnes HG, Lingjærde OC, Mills GB, Sahlberg KK, Børresen-Dale AL, Lehtiö J. Johansson HJ, et al. Among authors: naume b. Nat Commun. 2019 Apr 8;10(1):1600. doi: 10.1038/s41467-019-09018-y. Nat Commun. 2019. PMID: 30962452 Free PMC article.
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.
Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA. Andresen NK, et al. Among authors: naume b. J Immunother Cancer. 2024 Jan 19;12(1):e007990. doi: 10.1136/jitc-2023-007990. J Immunother Cancer. 2024. PMID: 38242720 Free PMC article. Clinical Trial.
DNA methylation at enhancers identifies distinct breast cancer lineages.
Fleischer T, Tekpli X, Mathelier A, Wang S, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E; Oslo Breast Cancer Research Consortium (OSBREAC); Børresen-Dale AL, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN. Fleischer T, et al. Among authors: naume b. Nat Commun. 2017 Nov 9;8(1):1379. doi: 10.1038/s41467-017-00510-x. Nat Commun. 2017. PMID: 29123100 Free PMC article.
128 results